Susha Cheriyedath

Susha Cheriyedath

Feature Writer

B.Sc Chemistry, M.Sc. Biochemistry

Susha is a scientific communication professional holding a Master's degree in Biochemistry, with expertise in Microbiology, Physiology, Biotechnology, and Nutrition. After a two-year tenure as a lecturer from 2000 to 2002, where she mentored undergraduates studying Biochemistry, she transitioned into editorial roles within scientific publishing. She has accumulated nearly two decades of experience in medical communication, assuming diverse roles in research, writing, editing, and editorial management.

See more

Passionate about health and nutrition, Susha is interested in various diet types, such as veganism, and their impact on the body and metabolism. She remains dedicated to staying current with the latest developments in the medical and health science fields. In her leisure time, she engages in gardening, cooking/baking, and sketching/painting. When not immersed in work, she can often be found tending to her garden (weather permitting) or engrossed in her sketching and painting projects.

See less

Articles from Susha

Emerging SARS-CoV-2 B.1.619 and B.1.620 variants in South Korea

Emerging SARS-CoV-2 B.1.619 and B.1.620 variants in South Korea

How effective are COVID-19 vaccines against the Omicron and Delta variants?

How effective are COVID-19 vaccines against the Omicron and Delta variants?

Booster dose elicits cross-reactive humoral immunity against SARS-CoV-2 Delta and Omicron variants

Booster dose elicits cross-reactive humoral immunity against SARS-CoV-2 Delta and Omicron variants

Efficacy of rapid antigen diagnostic tests for the detection of infectious individuals at mass gatherings

Efficacy of rapid antigen diagnostic tests for the detection of infectious individuals at mass gatherings

CDC report shows COVID vaccines safe for children, serious side effects rare

CDC report shows COVID vaccines safe for children, serious side effects rare

NAbs activity against SARS-CoV-2 variants, including Omicron, in an elderly vaccinated cohort

NAbs activity against SARS-CoV-2 variants, including Omicron, in an elderly vaccinated cohort

TriSb92 as a potential inhibitor against SARS-CoV-2 variants including Omicron

TriSb92 as a potential inhibitor against SARS-CoV-2 variants including Omicron

Factors associated with SARS-CoV-2 breakthrough infection in fully vaccinated individuals

Factors associated with SARS-CoV-2 breakthrough infection in fully vaccinated individuals

Clinical-grade soluble human ACE2 shown to inhibit SARS-CoV-2 Omicron variant

Clinical-grade soluble human ACE2 shown to inhibit SARS-CoV-2 Omicron variant

MRNA boosters shown to increase protection against SARS-CoV-2 Omicron

MRNA boosters shown to increase protection against SARS-CoV-2 Omicron

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.